(Q46344167)

21 December 2017

title

Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer (English)

1 reference

21 December 2017

1 reference

3

David A Flockhart

1 reference

21 December 2017

Zeruesenay Desta

series ordinal

2

object named as

Zeruesenay Desta

1 reference

21 December 2017

author name string

Wenjie Jessie Lu

series ordinal

1

1 reference

21 December 2017

language of work or name

English

0 references

publication date

9 March 2011

1 reference

21 December 2017

Breast Cancer Research and Treatment

published in

1 reference

21 December 2017

volume

131

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

473-481

1 reference

21 December 2017

The pharmacology and clinical uses of tamoxifen

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Tamoxifen, hot flashes and recurrence in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

Endoxifen, a new cornerstone of breast cancer therapy: demonstration of safety, tolerability, and systemic bioavailability in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

The effect of methadone and buprenorphine on human placental aromatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

X-ray structure of human aromatase reveals an androgen-specific active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1428-Z

10.1007/S10549-011-1428-Z

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017